ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-78 Cr | ₹-448 Cr | ₹-649 Cr | ₹-688 Cr | ₹-893 Cr |
What is the latest Total Non-Current Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹-78 Cr |
| Mar2025 | ₹-448 Cr |
| Mar2024 | ₹-649 Cr |
| Mar2023 | ₹-688 Cr |
| Mar2022 | ₹-893 Cr |
How is Total Non-Current Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-78 Cr | Negative | |
| Mar2025 | ₹-448 Cr | Negative | |
| Mar2024 | ₹-649 Cr | Negative | |
| Mar2023 | ₹-688 Cr | Negative | |
| Mar2022 | ₹-893 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹67,341.4 Cr | -2.5% | 0% | 11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -2.5% |
0% |
11.1% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses